A systematic review and meta-analysis of C-reactive protein levels found that low-grade inflammation — defined as CRP above 3 mg/L — was present in 27% of people with depression, with a confidence interval of 21 to 34%. That figure is worth reading carefully in both directions. It establishes that inflammation is a genuine feature for a substantial minority. It also means roughly three quarters did not show it, which is exactly the nuance that gets lost when inflammation is marketed as the cause of everything.

What Does the Evidence Actually Show?

The most consistent finding is that certain inflammatory markers are elevated in acute depression. Meta-analyses report increased circulating C-reactive protein, interleukin-6, interleukin-12 and tumor necrosis factor-alpha in people experiencing depressive episodes.

These associations hold up reasonably well statistically. Multiple meta-analyses have found reliable increases in peripheral inflammatory biomarkers in depressed patients compared with controls, robust after adjusting for age, sex, race, body mass index and smoking.

But effect sizes are modest — around d = 0.15 for CRP and d = 0.25 for IL-6 in one analysis. These are real, replicated differences at the group level rather than a diagnostic test. No blood marker currently identifies depression in an individual, and any clinic offering one is overstating the science.

How Would Inflammation Affect Mood at All?

Through several routes that are reasonably well characterized. Inflammatory signaling molecules can influence brain function via the vagus nerve, via active transport across the blood-brain barrier, and by affecting the barrier’s permeability.

Once that signaling reaches the brain, it changes how neurotransmitters are handled — including diverting tryptophan metabolism away from serotonin production — and affects neuroplasticity and neurotrophic support.

There is also an evolutionary reading worth knowing. The behavioral profile of an inflammatory response — social withdrawal, fatigue, loss of appetite and interest, increased sleep — closely resembles depressive symptoms. That cluster is functional during infection: it conserves energy and limits transmission. The hypothesis is that chronic low-grade inflammation may keep this adaptive program running when there is no infection to recover from.

Is Brain Fog Inflammation?

Sometimes it is a component. Cognitive symptoms during acute illness are a familiar experience of inflammatory signaling affecting cognition — the difficulty concentrating during a fever is not imagination.

Whether chronic low-grade inflammation produces persistent brain fog in otherwise healthy people is a more open question than online discussion suggests. The mechanism is plausible; the evidence in humans is considerably thinner than the confidence with which it is asserted.

The practical problem is that brain fog is a symptom with many causes, several of which are more common and more treatable than inflammation. Sleep disruption, thyroid dysfunction, anemia, B12 deficiency, medication effects, chronic stress, perimenopause and depression all produce it. Pursuing inflammation while an untreated sleep disorder is causing the symptom is a genuinely costly detour.

Where Does Chronic Stress Fit?

It connects the two, and the relationship runs in both directions. Prolonged stress activation influences immune function, and inflammatory signaling in turn affects the brain regions handling mood and cognition.

This bidirectionality matters because it undermines the search for a single first cause. Stress raises inflammation; inflammation affects the brain; an affected brain regulates stress less well. There is no clean starting point, which is frustrating diagnostically and useful practically — several entry points into the loop exist.

Sleep is central here too. Insufficient sleep is associated with elevated inflammatory markers, while the brain’s glymphatic clearance is most active during sleep, so persistent sleep disruption is worth addressing directly. So disrupted sleep sits inside the loop as both cause and consequence. Our article on the hidden cost of constant stress covers the structural side.

Should You Get Your CRP Tested?

It is a reasonable conversation to have with a physician, but be clear about what a result would and would not tell you.

CRP is non-specific. It rises with infection, injury, autoimmune activity, obesity, smoking and recent exercise. An elevated result indicates inflammation somewhere; it does not attribute your symptoms to it. A normal result does not rule out an inflammatory contribution either.

The honest position is that this is an active research area where treatment implications remain limited. Anti-inflammatory approaches to depression are under genuine investigation, and some show promise for people with elevated inflammatory markers — but this is not established clinical practice, and it is not a reason to self-treat with supplements. Discuss it with a doctor who can interpret results in the context of your full picture.

What Is Actually Worth Doing?

The interventions that reduce inflammation are largely the same ones that support brain health generally, which is convenient — you do not need a diagnosis to justify them.

Sleep is first, because insufficient sleep independently raises inflammatory markers and impairs the clearance that happens during it. Regular aerobic exercise has anti-inflammatory effects alongside its neurotrophic ones. Dietary patterns emphasizing whole foods and adequate omega-3 intake are reasonably supported, though far less dramatically than supplement marketing suggests.

And treat the treatable. If depression is present, it deserves proper treatment regardless of inflammatory status — see depression treatment. If sleep is disrupted, address it directly rather than waiting for inflammation to resolve it. Where nervous system dysregulation persists, brain mapping can show what is happening with regulation — a separate question from inflammatory status, and often a more actionable one.